Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

VA Consolidation in Intermediate-Risk AML

NCT07672262

Conditions: Acute Myeloid Leukemia, Consolidation Therapy, Hematologic Diseases, +7 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Kids With Iron Deficiency and Scoliosis

NCT06042699

Conditions: Adolescent Idiopathic Scoliosis, Anemia, Cognition Disorders, +17 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Recruiting

A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT04901936

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +6 more
Locations: Children's Hospital of Atlanta Atlanta, Georgia, United States

Motol University Hospital Prague, Czechia

Robert-Debré Hospital Paris Paris, France

Hospital Ampang Ampang, Malaysia

View Trial Details

Recruiting

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

NCT04515810

Conditions: Death, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Northwell Health Manhasset, New York, United States

Mount Sinai Hospital New York, United States

NYP/Weill Cornell Medical Center New York, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +16 more
Locations: Sobi Investigational Site Plovdiv, Bulgaria

Sobi Investigational Site Sofia, Bulgaria

Sobi Investigational Site Brest, France

Sobi Investigational Site Bron, France

View all 21 locations

View Trial Details

Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

NCT07143669

Conditions: Autonomic Nervous System Diseases, Bone Marrow Diseases, Chronic Disease, +23 more
Locations: AllerVie Clinical Research Birmingham, Alabama, United States

O'Neal Comprehensive Cancer Center at the UAB Birmingham, Alabama, United States

Kaiser Permanente San Diego San Diego, California, United States

Allergy & Asthma Clinical Research of the Bay Area Walnut Creek, California, United States

View all 19 locations

View Trial Details

Recruiting

Topical TOR-582 Treatment of Epistaxis in HHT

NCT07667413

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +19 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Stanford University Stanford, California, United States

MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center Miami, Florida, United States

View all 45 locations

View Trial Details

Recruiting

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07229235

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Novartis Investigative Site Alessandria, AL, Italy

Novartis Investigative Site Avellino, AV, Italy

Novartis Investigative Site Brescia, BS, Italy

Novartis Investigative Site Florence, FI, Italy

View Trial Details

Recruiting

Study of Out of Specification for Tisagenlecleucel

NCT04094311

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations: Novartis Investigative Site Hamilton, Ontario, Canada

Novartis Investigative Site Ottawa, Ontario, Canada

Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Toronto, Ontario, Canada

View all 54 locations

View Trial Details